Frequencies for first 10,000 rows of lit_ref variable in demo2016q4 dataset : Literature Reference | Freq. Percent Cum. ----------------------------------------+----------------------------------- | 9,428 94.28 94.28 , ARAKI K, SHIMADA K, SHIGEKAWA T, NA.. | 1 0.01 94.29 , ARMENTI D, CONSTANTINESCU S, AND MO.. | 1 0.01 94.30 , ARMENTI D, CONSTANTINESCU S, AND MO.. | 1 0.01 94.31 , ARMENTI D, CONSTANTINESCU S, AND MO.. | 1 0.01 94.32 , ARMENTI D, CONSTANTINESCU S, AND MO.. | 1 0.01 94.33 , ARMSTRONG D, COLLINS C, WANG T, SCH.. | 1 0.01 94.34 , BAGANZ L., KEKOW J., BUSSMANN A., K.. | 1 0.01 94.35 , BRIDGEWATER J, FALK S, CUMMINS S, W.. | 2 0.02 94.37 , CAYSSIALS E, LELEU X AND GUIDEZ S. .. | 1 0.01 94.38 , CLARINGBOLD P AND TURNER J HEMATOLO.. | 1 0.01 94.39 , CUNNINGHAM D, COIFFIER B, SOLAL-CEL.. | 1 0.01 94.40 , DAKHIL S, SALEH M, PIPERDI B, CLINE.. | 1 0.01 94.41 , DARRAS S, MORTIER L, GOEMINNE C, AU.. | 1 0.01 94.42 , DENISOVA R, VALIEVA S, BZAROVA T, S.. | 1 0.01 94.43 , DONADONI G, CABRAS M, PATTI C, MIAN.. | 1 0.01 94.44 , ESMAT G, OMAR R, ALLAM N, HASSANY M.. | 1 0.01 94.45 , FISCHER VON WEIKERSTHAL L,DECKER T,.. | 1 0.01 94.46 , FOUGEROU-LEURENT C, DE LEDINGHEN V,.. | 1 0.01 94.47 , GOUJON S, SIBIUDE J, BLANCHE S AND .. | 1 0.01 94.48 , GREER J, MORGAN D, CHEN H, PARK S A.. | 1 0.01 94.49 , GROVER N, OLAJIDE O, ASCH A, WALL J.. | 1 0.01 94.50 , GUNJIKAKE K, KANAMOTO A, ET AL. A C.. | 1 0.01 94.51 , HALLER D, MYKULOWYCZ K, ROSEN M, SO.. | 1 0.01 94.52 , HARDY-BESSARD A, CAPITAIN O, LORTHO.. | 1 0.01 94.53 , HUTMACHER M, ZIERHUT M, BECKER J-C,.. | 1 0.01 94.54 , JANCZEWSKA E, WAWRZYNOWICZ-SYCZEWSK.. | 1 0.01 94.55 , JARMUZEK W, RUBIK J, PIATOSA B, AND.. | 1 0.01 94.56 , KANG W, LIM D, PARK J, PARK Y, LIM.. | 1 0.01 94.57 , KIM J, KIM S, LEE S, YOON D, YANG D.. | 1 0.01 94.58 , KLINE J, BAUMAN J, GARDNER O, JONAK.. | 1 0.01 94.59 , KOLSTAD A, LAURELL A, RATY R, GRONB.. | 1 0.01 94.60 , KUSHNER B, KRAMER K, LEYCO S, BASU .. | 1 0.01 94.61 , LAWSON D, SALAMA A, KOON H, GUTHRIE.. | 1 0.01 94.62 , NAKAO M, ET AL. ACUTE HEPATIC FAILU.. | 1 0.01 94.63 , OGURA M, ITOH K, TANIWAKI M, ANDO K.. | 1 0.01 94.64 , PENSATO U, SANGALLI F, MOIOLA L, CO.. | 1 0.01 94.65 , ROUYER M, NOIZE P, LASSALLE R, BERN.. | 1 0.01 94.66 , RUSSO F, CAPOBIANCO G, MARCACCI G, .. | 1 0.01 94.67 , SAKALA M, MCLEAN C, PHILLIPS H, DAW.. | 1 0.01 94.68 , SHINODA K, TAMAKI S, KONO H, ASANUM.. | 1 0.01 94.69 , TAKAHATA M, KOKABU T, MATSUHASHI M .. | 1 0.01 94.70 , TANG G, RASTOGI P, GEYER C, ZOON C,.. | 1 0.01 94.71 , THEOCHARIS G, TANSARLI G, RAFAILIDI.. | 1 0.01 94.72 , TOBINAI K, HATAKE K, DAVIES A, CRUM.. | 1 0.01 94.73 , TORRI V, RIVA F, PORCU L, CICCHIELL.. | 1 0.01 94.74 , WALSH M, CHAUDHRY A, SMITH K AND JA.. | 1 0.01 94.75 , YASUE T, NAKAO K, OMACHI N, SHIROYA.. | 1 0.01 94.76 , YUAN Y, STEWART D, CHUNG S, KRUPER .. | 2 0.02 94.78 , YUAN Y, STEWART D, CHUNG S, KRUPER .. | 6 0.06 94.84 . ERRATUM: DACLATASVIR PLUS SOFOSBUVI.. | 1 0.01 94.85 A. AMIOT, J-C GRIMAUD, L. PEYRIN-BIRO.. | 1 0.01 94.86 A. AMIOT, J-C GRIMAUD, L. PEYRIN-BIRO.. | 1 0.01 94.87 A. AMIOT, J.-C. GRIMAUD, L. PEYRIN-BI.. | 2 0.02 94.89 A. AMIOT, J.-C. GRIMAUD, X. TRETON, J.. | 1 0.01 94.90 A. AMIOT, L. PEYRIN-BIROULET, C. STEF.. | 1 0.01 94.91 A. ORTEGA CARINCER, C. AMBROS CHECA, .. | 1 0.01 94.92 ACAR M, OGUZ M, DONMEZ Y, SENEL S. SU.. | 1 0.01 94.93 ACCORINTI, M.. MULTI-DRUG RESISTANCE .. | 1 0.01 94.94 AGARWAL S. SUCCESSFUL MANAGEMENT OF C.. | 1 0.01 94.95 AIZAWA S, ET AL.. MUSICAL HALLUCINATI.. | 1 0.01 94.96 AKASHI Y. TWO CASES OF SERIOUS HYPOKA.. | 1 0.01 94.97 AL OMRAN Y, AL HINDI S, HAWASH A. STE.. | 1 0.01 94.98 ALMADHYAN A. ANGIOEDEMA ASSOCIATED WI.. | 1 0.01 94.99 ALSHEHRI F, BAYOUMY M, ALAM M. BUSULF.. | 1 0.01 95.00 ALSHEHRI F., BAYOUMY M., ALAM M., ABO.. | 1 0.01 95.01 AOKI M. DRUG-HYPERSENSITIVITY SYNDROM.. | 1 0.01 95.02 ARELLANO AL, MARTIN M, MONERRIS M, LL.. | 1 0.01 95.03 ARIOKA M, NAKAO Y, FUKE N, KAWAMOTO S.. | 1 0.01 95.04 ARKILO D, HANNA J, DICKENS D, JUSTESE.. | 1 0.01 95.05 ARKILO D, HANNA J, DICKENS D, JUSTESE.. | 1 0.01 95.06 ASARI, S.. ACUTE GRAFT-VERSUS-HOST DI.. | 1 0.01 95.07 AURELIEN AMIOT, JEAN-CHARLES GRIMAUD,.. | 1 0.01 95.08 AYYALA RS, ARNOLD SD, BHATIA M, DASTG.. | 1 0.01 95.09 BACCHETTA J, GRECO M, BERTHOLET-THOMA.. | 1 0.01 95.10 BADAT Y, MEISSNER WG, LAHARIE D. DEMY.. | 1 0.01 95.11 BARATTA J.M., DYCK P.J.B., BRAND P., .. | 1 0.01 95.12 BARATTA JM, DYCK PJB, BRAND P, THAISE.. | 1 0.01 95.13 BARATTA JM, DYCK PJB, BRAND P, THAISE.. | 1 0.01 95.14 BARATTA JM, DYCK PJB, BRAND P, THAISE.. | 1 0.01 95.15 BARATTA JM, KARAM C. DEVELOPMENT OF N.. | 1 0.01 95.16 BAROKE E, SCHMIDT J, STRUNK A, WIES.. | 1 0.01 95.17 BARREIRA P,CADINHA S,DA SILVA M,MALHE.. | 1 0.01 95.18 BATH PM, WOODHOUSE L, SCUTT P, KRISHN.. | 1 0.01 95.19 BAUCKNEHT M, FERRARAZZO G, FIZ F, GHI.. | 1 0.01 95.20 BAWAADAM H, NAYDENOV S. USE OF HEMODI.. | 1 0.01 95.21 BEATTY CW, KO PR, NIXON J, GOSPE SM J.. | 1 0.01 95.22 BELAY TW, NUSAIR AR. APPARENT LISINOP.. | 1 0.01 95.23 BERGMANN T,NIELSEN F,BROSEN K,FILPPUL.. | 1 0.01 95.24 BHARMAPPANAVARA G, CHILDS A, GALLICHA.. | 2 0.02 95.26 BILORA, F.. AN UNUSUAL FINDING OF MAS.. | 1 0.01 95.27 BOONSARNGSUK V, SUWATANAPONGCHED T. A.. | 1 0.01 95.28 BOYCE AM, ESTRADA A, BRILLANTE BA, GU.. | 1 0.01 95.29 BRACKETT CC, BLOCH JD. PHENYTOIN AS A.. | 1 0.01 95.30 BRUCATO A, MASSIMO I, GATTORNO M, LAZ.. | 1 0.01 95.31 BURESCH, A. A FATAL CASE OF STRONGYLO.. | 1 0.01 95.32 BURNS D, CLESHAM K, HAUGHTON J, LANNO.. | 1 0.01 95.33 BURNS D, CLESHAM K, HODGSON Y, FREDRI.. | 4 0.04 95.37 CAIMI P, WILLIAM B, SILVA RONDON C, F.. | 1 0.01 95.38 CAPANOGLU M, VEZIR E, DIBEK MISIRLIOG.. | 1 0.01 95.39 CARCINER J, CHECA A, RODRIGUEZ C, LOR.. | 1 0.01 95.40 CARLO F, CRISTINA C, FOLLO M, STANZAN.. | 1 0.01 95.41 CARNICER J, CHECA A, RODRIGUEZ C, LOR.. | 1 0.01 95.42 CARNICER J, CHECA A, RODRIGUEZ C, LOR.. | 1 0.01 95.43 CASTELLANOS-GONZALEZ M, MARZAL-ALFARO.. | 1 0.01 95.44 CATANIA C, DE PAS TM, PELOSI G, MANZO.. | 1 0.01 95.45 CERCHIONE C, DE RENZO A, MASARONE M, .. | 1 0.01 95.46 CHAE J, YU D, WALKER M. PERCUTANEOUS,.. | 1 0.01 95.47 CHATTOPADHYAY S, DAS A, PAHARI S. FET.. | 15 0.15 95.62 CHAUDHARI DJ, GINN D. DOC! ^I SEE MON.. | 1 0.01 95.63 CHEN J, MAKIYAMA T, WURIYANGHAI Y, OH.. | 1 0.01 95.64 CHENG XIANGLIN, XU CHUANXIN. SUDDEN D.. | 1 0.01 95.65 CHIGA M. CONSIDERATION ON 2 CASES OF .. | 1 0.01 95.66 CHIGA M. CONSIDERATION ON 2 CASES OF .. | 1 0.01 95.67 CHUA-TUAN JL. CARDIAC SODIUM CHANNEL .. | 1 0.01 95.68 CLENIN GE, VAN ROOIJEN MM, BRAATHEN L.. | 1 0.01 95.69 COILLY A, FOUGEROU-LEURENT C, DE LEDI.. | 1 0.01 95.70 COLOMBA C, SIRACUSA L, MADONIA S, BON.. | 1 0.01 95.71 COLUCCIO E, VILLA MA, VILLA E, MORELA.. | 1 0.01 95.72 CORONA-RIVERA JR, BARRIOS-PRIETO E, N.. | 1 0.01 95.73 CORTELAZZO S, TARELLA C, GIANNI AM, B.. | 1 0.01 95.74 COURTOIS, F.. PREGABALIN-ASSOCIATED M.. | 1 0.01 95.75 CUNY P, HOUOT M, GINISTY S, HOROWICZ .. | 1 0.01 95.76 DA SILVA JR, PINHO R, PONTE A, SILVA .. | 1 0.01 95.77 DARLENSKI R. PATCH TESTING IN SYMMETR.. | 1 0.01 95.78 DASANU CA , BOCKORNY B. RECURRENT PSE.. | 1 0.01 95.79 DE CRUZ R, FERGUSON J, WEE JS, AKHRAS.. | 1 0.01 95.80 DE LA VEGA M, BAENAS D, RETAMOZO S, A.. | 1 0.01 95.81 DEJORAS E, VILLANUEVA-MISA A, PENSERG.. | 1 0.01 95.82 DEKEISTER, K. SUNITINIB-INDUCED SUDDE.. | 1 0.01 95.83 DESAI RS, DONNELLY HB. REPAIR OF A GL.. | 1 0.01 95.84 DHAMIJA RK, AGGARWAL R. LITHIUM INDUC.. | 1 0.01 95.85 DIERKSEN J, GONSOULIN M, WALTERSCHEID.. | 1 0.01 95.86 DIERKSEN J, GONSOULIN M, WALTERSCHEID.. | 1 0.01 95.87 DOEPKER B, HEALY W, CORTEZ E, ADKINS .. | 2 0.02 95.89 DONKOR J, VOHRA R, ARMENIAN P. ANALYS.. | 1 0.01 95.90 DOROKHINA EI, MAGOMEDOVA AU, SHEVELEV.. | 1 0.01 95.91 DUMKE R, STOLZ S, JACOBS E, JURETZEK .. | 1 0.01 95.92 DUNAIEF J; SONG D; LI Y; SONG Y; ZHAO.. | 1 0.01 95.93 D^HAENS, G.. EFFICACY AND SAFETY OF O.. | 1 0.01 95.94 EIJI U. TWO CASES OF BONE MARROW NECR.. | 1 0.01 95.95 ELLENBURG JT, JOSEY D JR. AN ATYPICAL.. | 1 0.01 95.96 ENKHTUVSHIN B, NAGASHIMA S, SAITO N, .. | 1 0.01 95.97 ESHAGHI A, ET AL.. MULTIPLE INFLUENZA.. | 1 0.01 95.98 FARAZESTANIAN M, YOUSEFI Z. UNCOMMON .. | 1 0.01 95.99 FINDIKLI E, GOKCE M, NACITARHAN V, FI.. | 1 0.01 96.00 FISCHER K,CRAMER P,BUSCH R,BOETTCHER .. | 1 0.01 96.01 FISHBEIN DA, GEBOY A, RUIZ ME, BOYCE .. | 1 0.01 96.02 FOPPIANI, L.. IODINE-INDUCED HYPERTHY.. | 1 0.01 96.03 FREDERICKS CA, ET AL.. FREDERICKS CA .. | 1 0.01 96.04 FUMIHIKO K. TREATMENT WITH LENVATINIB.. | 1 0.01 96.05 FURUHASHI H, ET AL.. A CASE OF PHOTOS.. | 1 0.01 96.06 GALLEGO N, ESTEPA R, MAMPASO F, GARCI.. | 1 0.01 96.07 GANZINELLI M, RULLI E, CAIOLA E, GARA.. | 1 0.01 96.08 GARIMELLA PS, RENNKE HG, STROM JA. AL.. | 1 0.01 96.09 GEBAUER MG, NYFORT-HANSEN K, HENSCHKE.. | 1 0.01 96.10 GILL EJ, CONTOS MJ, PENG TC. ACUTE FA.. | 1 0.01 96.11 GLATSTEIN M, SCOLNIK D, BENTUR Y. OCT.. | 1 0.01 96.12 GOH ACH, LUNDSTROM RJ. SPONTANEOUS CO.. | 1 0.01 96.13 GOMEZ G, STRAHOTIN C, CLARKE K. SEVER.. | 1 0.01 96.14 GOODMAN O, MILOWSKY M, KAPLAN J, HUSS.. | 1 0.01 96.15 GOTO A, TERAI S, NAKAMURA M, MATSUMOT.. | 1 0.01 96.16 GRANDVUILLEMIN A,RIPERT C,SGRO C,COLL.. | 1 0.01 96.17 GROW RW, ZAAS A. CASES FROM THE OSLER.. | 1 0.01 96.18 GUL HL, KARADAS O, AK L, TURK BORU U... | 1 0.01 96.19 GUTIERREZ-BARRIOS A, CAMACHO-FREIRE S.. | 1 0.01 96.20 H. KERR GRAHAM, MD, FRCS(ED), FRACS, .. | 1 0.01 96.21 H. KERR GRAHAM, MD, FRCS(ED), FRACS, .. | 3 0.03 96.24 H. KERR GRAHAM, MD, FRCS(ED), FRACS, .. | 1 0.01 96.25 HAARTSEN J, CM LEE S, SKIBINA O. VERY.. | 1 0.01 96.26 HADANO Y, OGAWA H, WAKEYAMA T, IWAMI .. | 1 0.01 96.27 HAEFNER M, SICILIANO RD, WIDMER LA, V.. | 1 0.01 96.28 HAMADA M ET.AL.. A STUDY OF CASES OF .. | 4 0.04 96.32 HAMER, MD H, KNAKE, MD S, SCHOMBURG, .. | 1 0.01 96.33 HAMMERSEN FJ, RUTHRICH MM, KLEBER M, .. | 1 0.01 96.34 HAMMERSEN J, RUTHRICH MM, KLEBER M, W.. | 1 0.01 96.35 HANSEN, D., FERNANDO H., POLLAN L.. F.. | 1 0.01 96.36 HARA T, JISHI R, MURATA S, SHIBATA K... | 1 0.01 96.37 HARA Y, MAEDA H, FUJIKURA M, MIZAWA K.. | 1 0.01 96.38 HARAGUCHI T, NISHIOKA J, YAMANO Y, YA.. | 1 0.01 96.39 HAROON N, RAZA SM, BHAT ZY. HYPOMAGNE.. | 1 0.01 96.40 HARUKI K, SHIBA H, NAKASEKO Y, TAKANO.. | 1 0.01 96.41 HASE I, ARAKAWA H, SAKUMA H, ET AL.. .. | 1 0.01 96.42 HASE I, ARAKAWA H, SAKUMA H, KANEKO F.. | 1 0.01 96.43 HAWKINS E, NIMAROFF M. VAGINAL EROSIO.. | 1 0.01 96.44 HAYASHI M, KOJIMA T, ISHIGURO N, KOBA.. | 1 0.01 96.45 HAYASHI S. CLINICAL FEATURE OF CEREBR.. | 1 0.01 96.46 HEARD K, BUI A, MLYNARCHEK SL, GREEN .. | 1 0.01 96.47 HERZOG J. PEDIATRIC BLOOD AND CANCER... | 1 0.01 96.48 HERZOG TJ, KUTARSKA E, BIDZINSKI M, S.. | 1 0.01 96.49 HIGO T, MIYAGAKI T, NAKAMURA F, SHINO.. | 1 0.01 96.50 HIGUCHI T, SATOH T, YOKOZEKI H. USING.. | 1 0.01 96.51 HILL E, NANJAPPA S, KIS B. KLEBSIELLA.. | 1 0.01 96.52 HILLIARD N, BROWN S, MITCHINSON S. A .. | 1 0.01 96.53 HIRAI T, ET AL.. RHABDOMYOLYSIS DUE T.. | 1 0.01 96.54 HIRAMINE Y, UTO H, IMAMURA Y, HIWAKI .. | 1 0.01 96.55 HIRAMINE Y, UTO H, IMAMURA Y, HIWAKI .. | 2 0.02 96.57 HIRAMINE Y, UTO H, IMAMURA Y, HIWAKI .. | 1 0.01 96.58 HIRAMINE YASUNARI, UTO HIROFUMI, IMAM.. | 1 0.01 96.59 HONDA Y, HATTORI Y, TOMIMORI S ET AL... | 1 0.01 96.60 HOSOI K, ARAI K, MATSUOKA K, SHIMIZU .. | 1 0.01 96.61 HOSOKAWA, K. A CASE OF MYOCLONUS CAUS.. | 1 0.01 96.62 HOU J-Y, LIU H-C, YEH T-C, SHEU J-C, .. | 3 0.03 96.65 HUANG X, CHERIPELLI B, LLOYD S, KALLA.. | 1 0.01 96.66 HUANG X, CHERIPELLI B, LLOYD S, KALLA.. | 1 0.01 96.67 HUANG X, CHERIPELLI B, LLOYD S, KALLA.. | 1 0.01 96.68 HUANG X, CHERIPELLI B, LLOYD S, KALLA.. | 1 0.01 96.69 HUANG X, CHERIPELLI B, LLOYD S, KALLA.. | 1 0.01 96.70 HURST J. A SIMPLE RASH OR A DEADLY KI.. | 1 0.01 96.71 HUSOVA, L.. CLADOPHIALOPHORA BANTIANA.. | 1 0.01 96.72 HUTSON, T.. AXITINIB VERSUS SORAFENIB.. | 1 0.01 96.73 HUTSON, T.. AXITINIB VERSUS SORAFENIB.. | 1 0.01 96.74 HUTSON, THOMAS E. AXITINIB VERSUS SOR.. | 1 0.01 96.75 IKEDA K, YANAGIHASHI M, SAWADA M, HAN.. | 1 0.01 96.76 INABA H, FUNABASHI T, ARIYASU H, FURU.. | 1 0.01 96.77 INIGUEZ -ARIZA N, RYDER M, BIBLE K. L.. | 1 0.01 96.78 INTRAVITREAL GENTAMICIN-INDUCED MACUL.. | 1 0.01 96.79 ISHIBASHI K, ISHIDA H, OKADA N, AMANO.. | 1 0.01 96.80 ISHIBASHI K, ISHIDA H, OKADA N, AMANO.. | 1 0.01 96.81 ISHIKAWA R, YONEYAMA R, MIYAJIMA K, K.. | 1 0.01 96.82 ITO T, KENMOCHI T, MARUYAMA M, AKUTSU.. | 1 0.01 96.83 IWAMI D, MORITA KEN, OISHI YUICHIRO, .. | 1 0.01 96.84 IWASAKI H, SUE H, NAKAYAMA K. A CASE .. | 1 0.01 96.85 IWASAKI, M.. A CASE OF SEVERE HYPOTEN.. | 1 0.01 96.86 J GOH, K PITTMAN, Y C ANTILL, ET AL.... | 1 0.01 96.87 JAMES A, LARSON T. ACUTE RENAL FAILUR.. | 1 0.01 96.88 JASIM S, CHINTAKUNTLAWAR A, BIBLE K. .. | 1 0.01 96.89 JENSEN, D.E.. NEPHROCALCINOSIS: A POT.. | 1 0.01 96.90 K. S. F. KHOW, T. Y. YONG, WILCKEN H .. | 1 0.01 96.91 K. TOSHIYUKI, K. KEIKO, A. SHOKO, ET.. | 1 0.01 96.92 KABURAKI Y. (1)-65: CONSIDERATION OF .. | 1 0.01 96.93 KAKAR R, PAUGH H, JAWORSKY C. LINEAR .. | 1 0.01 96.94 KAKEYA H, IZUMIKAWA K, YAMADA K, NARI.. | 1 0.01 96.95 KAMEI, M.. SUCCESSFUL TREATMENT WITH .. | 1 0.01 96.96 KANAYAMA A, ET AL. THREE CASES IN WHI.. | 1 0.01 96.97 KANEKO H, SUZUKI M. A CASE OF SACRAL .. | 1 0.01 96.98 KAPILA A, CHHABRA L, LOCKE AD, PATEL .. | 1 0.01 96.99 KARACHALIOU N, SALOUSTROS E, VAMVAKAS.. | 1 0.01 97.00 KARCZMAREK-BOROWSKA B, DRZYMALA M, GO.. | 1 0.01 97.01 KARINEN R, TUV SS, ROGDE S, PERES MD,.. | 1 0.01 97.02 KASHIWAGUMA D, KAWASHIMA H, TAKAHASHI.. | 1 0.01 97.03 KATO H, FURUYA Y, MIYAZAWA Y, MIYAO T.. | 2 0.02 97.05 KATSUMATA J, KOUYA, NAKAJIMA M, ET AL.. | 1 0.01 97.06 KAWAI K, SHIRAI T, SUZUKI K, CHIDA K,.. | 1 0.01 97.07 KAWARATANI H, YOSHIJI H, NOGUCHI R, M.. | 1 0.01 97.08 KAWASHIMA Y, MIKI A, OKAMURA T, AOYAG.. | 1 0.01 97.09 KEGLER R, RENTSCH D, NOWOTNIK J, BUTT.. | 1 0.01 97.10 KELLY K. INDATUXIMAB RAVTANSINE (BT06.. | 1 0.01 97.11 KENICHI N. TWO CASES OF STEVENS - JOH.. | 1 0.01 97.12 KENJI MATSUMOTO, RENA WATANABE, HIROY.. | 1 0.01 97.13 KENT S, KENT J, ALLEN L. POROUS POLYE.. | 1 0.01 97.14 KHAJURIA B, KHAJURIA M, AGRAWAL Y. MY.. | 2 0.02 97.16 KIKUCHI T, TAMADA Y, TAKAHASHI K, TAK.. | 1 0.01 97.17 KIKUKAWA Y, YUKI H, HIRATA S, IDE K, .. | 1 0.01 97.18 KINNO. ACUTE GENERALIZED EXANTHOMATOU.. | 1 0.01 97.19 KINZEL, O.. TOXIC CEREBELLAR SYNDROME.. | 1 0.01 97.20 KITANI K. AN EXAMINATION OF CASES TRE.. | 1 0.01 97.21 KLEEBERG U, LINDE H, GUNTHER G, TESSE.. | 1 0.01 97.22 KLEIN. A.. SPONTANEOUS REGRESSION OF .. | 1 0.01 97.23 KODA T, KOIKE J, KURIHARA A, ET AL. A.. | 1 0.01 97.24 KODAIRA M, OGUSHI K, YAMAGATA S, WATA.. | 1 0.01 97.25 KOEBERLE U, STAMMSCHULTE T, TEIPEL, E.. | 1 0.01 97.26 KOMEI ISHIKAWA ET.AL. A CASE OF ARIPI.. | 1 0.01 97.27 KOO JS, KIM YS, KIM JS, KIM N, KIM ES.. | 1 0.01 97.28 KORKES HA, DE OLIVEIRA LG, BERLINCK L.. | 1 0.01 97.29 KORKES HA, DE OLIVEIRA LG, BERLINCK L.. | 1 0.01 97.30 KORZENIK J R. INFLAMMATORY BOWEL DISE.. | 1 0.01 97.31 KORZENIK J.R.. INFLAMMATORY BOWEL DIS.. | 1 0.01 97.32 KORZENIK J.R.. INFLAMMATORY BOWEL DIS.. | 1 0.01 97.33 KOTHARI, S.. DEXAMETHASONE-INDUCED CO.. | 1 0.01 97.34 KUBOTA M, KAWADA A, MAKI A, ET. AL.. .. | 1 0.01 97.35 KURAHACHI T. AN ONCOLOGIC EMERGENCY C.. | 1 0.01 97.36 KURATA K, YAKUSHIJIN K, MIYATA Y, KAK.. | 1 0.01 97.37 LA REVUE PRESCRIRE, DATE: 2016, VOL: .. | 1 0.01 97.38 LAENGVEJKAL P, JULAYANONT P, TANTIKIT.. | 1 0.01 97.39 LAGARCE L, BERNARD N, CARLIER P, PHEL.. | 1 0.01 97.40 LAHAM, G.. SURVEILLANCE REGISTRY OF S.. | 1 0.01 97.41 LAMY O., AUBRY-ROZIER B., STOLL D. ET.. | 1 0.01 97.42 LAMY O., GONZALEZ-RODRIGUEZ E., STOLL.. | 1 0.01 97.43 LAW J, RECCHIA F, MORRISON D, DONAHUE.. | 1 0.01 97.44 LAW J, RECCHIA F, MORRISON D, DONAHUE.. | 1 0.01 97.45 LEE DH, KEYMEULEN B, HILBRANDS R, LIN.. | 2 0.02 97.47 LEE E, RULAND S, LEBOEUF N, WEN P AND.. | 1 0.01 97.48 LEGARTH RA, CHRISTENSEN M, CALUM H, K.. | 1 0.01 97.49 LINEAR IGA BULLOUS DERMATOSIS DUE TO .. | 1 0.01 97.50 LIU J, SIMPSON J, RIZEQ M, BURKE R. B.. | 1 0.01 97.51 LJ?STAD, U.. AUTOIMMUNE MYOPATHY ASSO.. | 1 0.01 97.52 LO-CASTRO A, BRANCATI F, DIGILIO MC, .. | 1 0.01 97.53 LONG L, LEI H, LI R AND LI WEI. EPIDE.. | 1 0.01 97.54 LUKASIK-GLEBOCKA M, KLIMASZYK D. ALCO.. | 1 0.01 97.55 MACIULAITYTE I, KASINSKAITE S, BLIUDZ.. | 1 0.01 97.56 MAKINODAN A., OTAKARA E., SHIRAI T ET.. | 1 0.01 97.57 MAMO A, BAIG A, AZAM M, RHO Y, SAHEBJ.. | 1 0.01 97.58 MANOHARAN S, MUIR J, WILLIAMSON R. GI.. | 1 0.01 97.59 MANOHARAN S, MUIR J. GALLBLADDER VASC.. | 1 0.01 97.60 MARTINEZ F, RABE K, FERGUSON G, FABBR.. | 1 0.01 97.61 MASON JO, PATEL SA. BULL^S EYE MACULO.. | 1 0.01 97.62 MASUDA K, MIYAWAKI S, FUJIYAMA M, ET .. | 1 0.01 97.63 MATSUMOTO K. CASES OF CEREBRAL HEMORR.. | 1 0.01 97.64 MATSUMOTO K. CASES OF CEREBRAL HEMORR.. | 1 0.01 97.65 MATSUMOTO K.. PHASE II TRIAL OF ORAL .. | 1 0.01 97.66 MATSUMOTO, K.. PHASE II TRIAL OF ORAL.. | 1 0.01 97.67 MATSUNAGA H, HIGASHI K, IIDA M. A CAS.. | 1 0.01 97.68 MATSUYAMA S, KURAMOTO T, TANAKA R, HA.. | 1 0.01 97.69 MATSUZAKI Y, YAGUCHI T, NAKANO H, SAW.. | 1 0.01 97.70 MAWRI, S.. VANCOMYCIN-INDUCED ACUTE G.. | 1 0.01 97.71 MAYA Y, FUJITA Y, NAKAYAMA C, ET AL. .. | 1 0.01 97.72 MAYUKO IGARASHI. SAFETY AND TOLERABIL.. | 1 0.01 97.73 MBUVAH F, VENUR VA, KISTANGARI G.. TH.. | 1 0.01 97.74 MCLEON M. ACUTE PULMONARY EMBOLISM. C.. | 1 0.01 97.75 MCMAHON AW, WHARTON GT, THORNTON P, D.. | 1 0.01 97.76 MELLEMA WW, BURGERS SA, SMIT EF. TUMO.. | 1 0.01 97.77 MERTZ D, BATTEGAY M, MARZOLINI C, MAY.. | 1 0.01 97.78 METZGER N, MOMARY K. A PATIENT WITH H.. | 1 0.01 97.79 MEY U, BRUGGER W, BARGETZI M, SCHWARB.. | 1 0.01 97.80 MIGUEL GL, HERMOSA ZE, URECH GM, SAN.. | 1 0.01 97.81 MIKAMI S, AYAKO M, KAZUHIKO O, SHIRO .. | 1 0.01 97.82 MILLAR A, ELLIS M, MOLLEE P, COCHRANE.. | 1 0.01 97.83 MISHRA A, PANDYA HV, DAVE N, MATHEW M.. | 1 0.01 97.84 MIURA T, HONMA R, IIDA T. A CASE OF D.. | 1 0.01 97.85 MIYAKE S, SUGITA MAKIO, NAGAOKA KIYOS.. | 1 0.01 97.86 MONTALBAN-BRAVO G. A CLINICAL TRIAL F.. | 1 0.01 97.87 MORDAL G, PARKER K, NAMTVEDT T. A KID.. | 1 0.01 97.88 MORDAL GCE, PARKER K, NAMTVEDT T. EN .. | 2 0.02 97.90 MORE P, LAHERI VV, WAIGANKAR T, WAGH .. | 1 0.01 97.91 MORENO PLANAS J, LARRUBIA MARFIL J, S.. | 1 0.01 97.92 MORENO PLANAS J, MARTINEZ RODENAS P, .. | 1 0.01 97.93 MORIYA A, ANDO T. THE STUDY OF THE SE.. | 2 0.02 97.95 MOWRY JB, SPYKER DA, CANTILENA LR JR,.. | 1 0.01 97.96 MOWRY, J./MCMILLAN N., BROOKS DE., SH.. | 1 0.01 97.97 MUKHAMETSHINA, G.. IMA901, A MULTIPEP.. | 1 0.01 97.98 MULLINS ME, VITKOVITSKY IV. HEMOLYSIS.. | 1 0.01 97.99 MUNIPALLE PC, GARUD T, LIGHT D. DIAPH.. | 1 0.01 98.00 MURAKAMI K, MIZUMOTO E, MORI N, IMOTO.. | 1 0.01 98.01 MURAMATSU K. A CASE OF SCHIZOPHRENIA .. | 1 0.01 98.02 MURTAZA A,SIRAJ A. A RARE BUT LIFE TH.. | 1 0.01 98.03 N. MEHSEN-CETRE; M.KOSTINE; B.BANNWAR.. | 1 0.01 98.04 NADEEM S, HASHMAT S, DEFREITA MJ, WES.. | 1 0.01 98.05 NADEEM S, HASHMAT S, DEFREITA MJ, WES.. | 3 0.03 98.08 NAGAI Y, YOKOGAWA N, SHIMADA K, SUGII.. | 1 0.01 98.09 NAGANUMA M, SHIGA T, NAGAO T, SUZUKI .. | 1 0.01 98.10 NAITO, N.. ANALYSIS ON THE PATIENTS R.. | 1 0.01 98.11 NAKAJIN T, YAMAGUCHI M, HOSOKAWA A, E.. | 1 0.01 98.12 NAT AS, NAT A, HARRISON J, RANE M. LI.. | 1 0.01 98.13 NGUYEN T.A.. HOSPITALIZATION FOR DRUG.. | 3 0.03 98.16 NGUYEN-MICHEL VH, BORNAND A, BALATHAZ.. | 1 0.01 98.17 NIJHOF I, ZWEEGMAN S, LEVIN M, KOENE .. | 1 0.01 98.18 NIMBALKAR, S.. NEAR FATAL CASE OF AML.. | 1 0.01 98.19 NINAN, J.. IMIPENEM-CILASTATIN-INDUCE.. | 1 0.01 98.20 NISHIKAWA S, TANI MAYUKO, MATSUI TOMO.. | 1 0.01 98.21 NISHIKAWA, T.. A CASE OF COMPLEX CYST.. | 1 0.01 98.22 NISHIMI D, KAMIYA N, KAMIJIMA S, ET A.. | 1 0.01 98.23 NODA T. TREATMENT STRATEGY AIMING FOR.. | 1 0.01 98.24 NOMOTO M. A CASE OF DEEP VEIN THROMBO.. | 1 0.01 98.25 NORIHIDE FUKUSHIMA ET AL. EXPERIENCE .. | 1 0.01 98.26 NOTO R, KAMIURA N, KINOSHITA K, SASAK.. | 1 0.01 98.27 NZWALO H, FERREIRA L, PERALTA R, BENT.. | 1 0.01 98.28 O LAMY, B AUBRY-ROZIER, D STOLL, ET.A.. | 1 0.01 98.29 OBERG C, HIENSCH R, POOR H. OMBITASVI.. | 2 0.02 98.31 OFLAZOGLU, U.. CASE REPORT OF A RENAL.. | 1 0.01 98.32 OGURA M, TOBINAI K, HATAKE K, DAVIES .. | 1 0.01 98.33 OHKAWA S, OKUSAKA T, ISAYAMA H, FUKUT.. | 2 0.02 98.35 OKADA Y. PARADOXICAL HYPOTENSION IN R.. | 1 0.01 98.36 OKAMURA I, NAKAMURA Y, KATSURADA Y, S.. | 1 0.01 98.37 OKAZAKI F, MORIDERA K, SHUDO A, ET AL.. | 1 0.01 98.38 OKUMURA, Y.. THERAPY-RELATED ACUTE MY.. | 1 0.01 98.39 OMBITASVIR-PARITAPREVIR-RITONAVIR-DAS.. | 1 0.01 98.40 ORLIAGUET G, HAMZA J, COULOIGNER V, D.. | 1 0.01 98.41 OTSUKA Y, FUNASAKA Y, KATO T, ITO M, .. | 1 0.01 98.42 OZEKI T, OMORI N, KUWABARA K, ADOMI S.. | 1 0.01 98.43 OZGULER Y, HATEMI G, UGURLU S, SEY.. | 1 0.01 98.44 O^CONNOR K, BURKE R, RIMINTON S. HOSP.. | 1 0.01 98.45 PAGE CB, MOSTAFA A, SAIAO A, MEDLEY G.. | 1 0.01 98.46 PAGE, LOT. PHEOCHROMOCYTOMA WITH PRED.. | 1 0.01 98.47 PAI MV, NAMBIAR J, CHANDRAMOULI A.. R.. | 1 0.01 98.48 PANICI PB, MARCHETTI C, MUSELLA A, MO.. | 1 0.01 98.49 PAPASTERGIOU V, SKORDA L, LISGOS P AN.. | 1 0.01 98.50 PATEL H, WILCHES L, GUERRERO J. TIMOL.. | 1 0.01 98.51 PATEL S, MALHOTRA R. GABAPENTIN RELAT.. | 1 0.01 98.52 PENA TA, SOUBANI AO, SAMAVATI L. ASPE.. | 1 0.01 98.53 PHAM T, SCOFIELD R 13-CIS-RETINOIC AC.. | 1 0.01 98.54 PILAR TB, CRISTINA SP, ENRIQUE SC, .. | 1 0.01 98.55 POENISCH W, BOURGEOIS M, MOLL B, HEYN.. | 1 0.01 98.56 PONISCH A,ANDREA M,WAGNER I,HAMMERSCH.. | 1 0.01 98.57 PONZETTI A, PINTA F, SPADI R, MECCA C.. | 1 0.01 98.58 POVLSEN B, POVLSEN SD. STEROID INJECT.. | 1 0.01 98.59 POZZI S, BADIALI S, CORSO A, MUSTO P,.. | 1 0.01 98.60 PRICE J, MURPHY R, SHVACHKO V, PAULY .. | 1 0.01 98.61 PU J, CHAN R, NG G, LEUNG G, HUNG K A.. | 1 0.01 98.62 PUTRUS A, AL-GHANOUDI A, ALSAMMAN MA,.. | 1 0.01 98.63 QASEM A, BIN ABDULHAK A, ALY A AND MO.. | 1 0.01 98.64 RADTKE FM, FRANCK M, HAGEMANN L, SEE.. | 1 0.01 98.65 RADTKE FM, FRANCK M, HAGEMANN L, SEEL.. | 1 0.01 98.66 RANKIN H, ZWICKER K, TRENOR C. CAUTIO.. | 8 0.08 98.74 RECKOVA, M.. A PATIENT ON LONG-TERM T.. | 1 0.01 98.75 REPORTER KNONWN TO HEALTH AUTHORITY. .. | 1 0.01 98.76 RIPPLE MG, PESTANER JP, LEVINE BS, SM.. | 1 0.01 98.77 RODRIGUEZ B, WILHELM A, KOKKO KE. LIP.. | 1 0.01 98.78 ROMERO J, MEDRANO F, GOODMAN D, GOLIV.. | 1 0.01 98.79 ROMIOPOULOS, I.. FULMINANT EPSTEIN-BA.. | 1 0.01 98.80 ROOHI F, GROPEN T, KULA RW. SUDDEN UN.. | 1 0.01 98.81 ROSAS, A.. PHEOCHROMOCYTOMA CRISIS IN.. | 1 0.01 98.82 ROTAR Z, TOMSIC M. INCIDENCE RATE OF .. | 1 0.01 98.83 RUELLAN AL, VEYRAC G, JOYAU C, LE VAL.. | 2 0.02 98.85 RYAN CW, MERIMSKY O, AGULNIK M, BLAY .. | 1 0.01 98.86 S. LI, T. NIIKURA, T. IWAKURA, ET. AL.. | 1 0.01 98.87 SACKS L, HUSSAIN E. PLASMAPHERESIS SI.. | 1 0.01 98.88 SADATSUKI M, OOISHI H, NAKANISHI M, E.. | 1 0.01 98.89 SAITO T. A CASE OF HODGKIN^S LYMPHOMA.. | 1 0.01 98.90 SAKATA N. CLINICAL OUTCOME OF PATIENT.. | 1 0.01 98.91 SAKI N. EFFECTIVENESS OF LENVATINIB F.. | 1 0.01 98.92 SALOUAGE I, SASSI MB, GAIES E, CHARFI.. | 1 0.01 98.93 SANCHORAWALA V. POMALIDOMIDE AND DEXA.. | 1 0.01 98.94 SATO Y, K N, N Y. SEROTONIN SYNDROME .. | 1 0.01 98.95 SATTLER F, CASTANEDA-SCEPPA C, BINDER.. | 1 0.01 98.96 SCHIESSL B, SCHNEIDER KT, ZIMMERMANN .. | 1 0.01 98.97 SCHIODT M, SCHIODT M, WEXELL C, HERLO.. | 1 0.01 98.98 SCHLENK R, STEGELMANN F, ANDREAS R, J.. | 1 0.01 98.99 SCHULER E, HASSE D, GIAGOUNIDIS A, BR.. | 1 0.01 99.00 SCHUMAN-OLIVIER Z, NOORDSY DL, BRUNET.. | 1 0.01 99.01 SENOH A. CROHN DISEASE SUCCESSFULLY T.. | 1 0.01 99.02 SENTHILKUMARAN, S.. IN RESPONSE TO GL.. | 1 0.01 99.03 SHARMA V, SHARMA P.. PERIPARTUM-ONSET.. | 1 0.01 99.04 SHER L, LANDERS S. BIPOLAR DISORDER, .. | 1 0.01 99.05 SHIMA A, SHINDE A, KAGEYAMA T, ET AL... | 1 0.01 99.06 SHIMADA T, ITOBAYASHI E, ISHIKAWA K, .. | 1 0.01 99.07 SHIMAKAWA S, NOMURA S, OGINO M, FUKUI.. | 1 0.01 99.08 SHIN Y, KIM J, MOON J, YOU R, PARK J,.. | 2 0.02 99.10 SHINOZAKI T. EXPERIENCE OF EARLY ABIR.. | 1 0.01 99.11 SHIWAKU E, DOTE S, NOZAKI A, KOBAYSAH.. | 1 0.01 99.12 SHOKO IGA, ET AL.. A CASE OF MALIGNAN.. | 1 0.01 99.13 SHUDO ATSUSHI, KISHIMOTO HIROMITSU, K.. | 1 0.01 99.14 SIDDIQI TA, HILL J, HUCKLEBERRY Y, PA.. | 1 0.01 99.15 SINGH S; BHATTAD S; GUPTA A; SURI D; .. | 4 0.04 99.19 SKLAR GE. HEMOLYSIS AS A POTENTIAL CO.. | 1 0.01 99.20 SONE S, YOSHINO A, KAWAHARA Y ET AL.... | 1 0.01 99.21 SORENSEN GV, RUBAK SLM. ANAPHYLAXIS T.. | 1 0.01 99.22 SOZA A, LABBE P, ARRESE M, RIQUELME A.. | 1 0.01 99.23 SPINA M, LUMINARI S, SALVI F, PASSAMO.. | 2 0.02 99.25 SPINA M, LUMINARI S, SALVI F, PASSAMO.. | 1 0.01 99.26 STAIB L, LINK K AND HENNE-BRUNS D. IN.. | 1 0.01 99.27 STOHR W, ODDERSHEDE L, ARENAS-PINTO .. | 1 0.01 99.28 STRAKA C, SCHAFER-ECKART K, BASSERMAN.. | 1 0.01 99.29 STRAUSS L, LODER E, RIZZOLI P. TRANSI.. | 1 0.01 99.30 STRZELECKI, D.. HYPOMANIA AFTER AUGME.. | 1 0.01 99.31 STUDY ON IDIOPATHIC CEREBRAL HEMORRHA.. | 1 0.01 99.32 SUBAT-DEZULOVIC M, SLAVIC I, ROZMANIC.. | 1 0.01 99.33 TAHER R, FEARS R, LARSON J, CHANG W, .. | 1 0.01 99.34 TAKADA, T.. EFFICACY AND SAFETY OF LO.. | 1 0.01 99.35 TAKADA, T.. EFFICACY AND SAFETY OF LO.. | 4 0.04 99.39 TAKESHIMA F, YOSHIKAWA D, HIGASHI S, .. | 1 0.01 99.40 TAKESHIMA M, ISHIKAWA H, SHIMIZU T, T.. | 1 0.01 99.41 TAKESHITA M, YAMADA K, Y. OSHIRO Y AN.. | 1 0.01 99.42 TANAKA, Y.. A CASE OF METHOTREXATE-AS.. | 1 0.01 99.43 TANEJA AK, SANTOS DCB. STEROID-INDUCE.. | 1 0.01 99.44 TANI T, ABE S, HONMA T, ET AL. A CASE.. | 1 0.01 99.45 TANTIKITTICHAIKUL, S; JOHNSON, J; LAE.. | 1 0.01 99.46 TEIVE, H.. STATIN-ASSOCIATED CEREBELL.. | 1 0.01 99.47 TETSUTANI M, UNZAI TAKASHI, MURAO KAZ.. | 1 0.01 99.48 THAISETTHAWATKUL P, SUNDELL R, ROBERT.. | 1 0.01 99.49 THOMAS KC, WILKINS DG, CURRY S, GREY .. | 1 0.01 99.50 THOMAS KC, WILKINS DG, CURRY S, GREY .. | 1 0.01 99.51 TOLUNAY O, CELIK T, KOMUR M, GEZGIN A.. | 1 0.01 99.52 TOSHITAKA KOINUMA ET AL.. CASE REPORT.. | 1 0.01 99.53 TSAU Y, CHEIN YH, LIN KH, LEE T, LU M.. | 1 0.01 99.54 TSENG P, BANNOUT F.. LEVETIRACETAM MA.. | 1 0.01 99.55 TSIEN MZ, CORDOVA J, QADIR A, ZHAO L,.. | 1 0.01 99.56 TSIRIGOTIS P., YERUSHALMI R., GKIRKAS.. | 1 0.01 99.57 TSUJI T, MIURA M, YANAI M, ITAMI H , .. | 1 0.01 99.58 TULL T, PAPINENI P, COOK C, MEE J, BO.. | 1 0.01 99.59 TURHAN AG. REVERSIBLE SKIN TELANGIECT.. | 1 0.01 99.60 UCA, A U.. VARENICLINE-INDUCED ACUTE .. | 1 0.01 99.61 UMEYAMA Y, TAKAZONO T, YOSHIOLA S, SU.. | 1 0.01 99.62 UMEZAWA N, KUSAKABE A, KAWASAKI Y, TO.. | 1 0.01 99.63 USUMOTO Y, KUDO K, SAMESHIMA N, SATO .. | 1 0.01 99.64 VAN DEN BERG SAA, VERWER PE, IDEMA RN.. | 1 0.01 99.65 VAN NGUYEN T, SINNOLLAREDDY MG. BISPH.. | 1 0.01 99.66 VANG T, ROSENZWEIG M, BRUHN CH, POLCW.. | 1 0.01 99.67 VARMA P, ROY P, JAIN A, ET AL. HYPONA.. | 1 0.01 99.68 VARMA P, YEAMAN F, HOLT D, MOORE G, Y.. | 1 0.01 99.69 VELILLA MOLINER J, GIMENEZ VALVERDE A.. | 1 0.01 99.70 WACHIRA JK, JENSEN CH, RHONE K. DOXYC.. | 1 0.01 99.71 WAKAHARA, K.. TWO CASES OF LYMPHANGIO.. | 1 0.01 99.72 WALDMAN L, REDDY SB, KASSIM A, DETTLO.. | 1 0.01 99.73 WARDROPE K, MANSON L, METCALFE W AND .. | 1 0.01 99.74 WATSON E, COOPER D. VENTRICULAR TACHY.. | 1 0.01 99.75 WEBER-SCHOENDORFER C, OPPERMANN M, WA.. | 1 0.01 99.76 WESTERGREN T, HJELMELAND K, KRISTOFFE.. | 1 0.01 99.77 WHEDON JM, RUGO NA, LUX K. CHALLENGES.. | 1 0.01 99.78 WICK F, BALLMER PE, HALLER A. ACUTE E.. | 1 0.01 99.79 WIGGINS A, BALASUBRAMANIAN T, FERRARO.. | 1 0.01 99.80 WILLNER N, STORCH S, TADMOR T, SCHIFF.. | 1 0.01 99.81 WINQVIST M, MOZAFFARI F, PALMA M, SYL.. | 1 0.01 99.82 WITTMANN O, SADOT E, BISKER-KASSIF O,.. | 1 0.01 99.83 WONG SH, RICE C. METFORMIN IN GESTATI.. | 3 0.03 99.86 WU CW, WU YJ, WU CC. CLOPIDOGREL-ASSO.. | 2 0.02 99.88 XIAOJING LI, LING JI, YANYAN Z, XIAOL.. | 1 0.01 99.89 Y G KIM. MESENTERIC VASCULITIS AFTER .. | 1 0.01 99.90 YAGISAWA M, TAKASAKA T, SUZUKI K, ET .. | 1 0.01 99.91 YAGISAWA M. A CASE OF REFRACTORY ULCE.. | 1 0.01 99.92 YAMASHITA S, MIYAOKA T, NAGAHAMA M, I.. | 1 0.01 99.93 YAMAZAKI A, WATANABE M, KIKUMOTO N, M.. | 1 0.01 99.94 YEE A. RICOLINOSTAT PLUS LENALIDOMIDE.. | 1 0.01 99.95 YOKOYAMA T. FOR WHICH CASES SHOULD CL.. | 1 0.01 99.96 YORIZUMI M. TWO CASES OF BREAST CANCE.. | 1 0.01 99.97 YOROZU, S.. CLINICOPATHOLOGICAL STUDY.. | 1 0.01 99.98 YUKI F. A CASE OF PSORIASIS VULGARIS .. | 1 0.01 99.99 ZYCHOWSKA M, BATYCKA-BARAN A, BARAN W.. | 1 0.01 100.00 ----------------------------------------+----------------------------------- Total | 10,000 100.00 by Jean Roth , jroth@nber.org , 18 Sep 2017